| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/03/2001 | CA2388337A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | CA2388298A1 The use of csf-1 inhibitors |
| 05/03/2001 | CA2387921A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | CA2387506A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/02/2001 | EP1096018A1 Complementation cells comprising an inducer and/or a repressor |
| 05/02/2001 | EP1095132A1 Methods for implanting cells |
| 05/02/2001 | EP1094829A2 Methods for accelerating bone and cartilage growth and repair |
| 05/02/2001 | EP1094825A2 Pharmaceutical grade st. john's wort |
| 05/02/2001 | EP1094824A1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 05/02/2001 | EP1094792A1 Materials and methods relating to encapsulation |
| 05/02/2001 | EP1094703A2 Improved methods for storing neural cells |
| 05/02/2001 | EP1006801A4 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
| 05/02/2001 | EP0817860B1 Pseudotyped retroviral particles |
| 05/02/2001 | EP0814819A4 Sertoli cells as transplantation facilitator for cell transplantation |
| 05/02/2001 | CN1293707A Development of normal offspring from oocytes injected with freeze-bried spermatozoa |
| 05/02/2001 | CN1293574A Materials for preventing arteriosclerosis, Immunopotentiating meterials, vertegrates fed with these materials and eggs thereof |
| 05/02/2001 | CN1293245A Process for separating worm kinase |
| 05/02/2001 | CN1293062A Chinese medicine for treating alopecia |
| 05/02/2001 | CN1293053A Medicine for treating facial paralysis and its preparing process |
| 05/02/2001 | CN1293050A Plaster |
| 05/02/2001 | CN1293049A 'Shexingkeyu' capsule for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 05/02/2001 | CN1293043A Honeycomb honey and its preparing process |
| 05/02/2001 | CN1293042A Propolis honey and its preparing process |
| 05/02/2001 | CN1293041A Functional food for protecting liver and medicine for preventing and curing hepatitides prepared from loach and its preparing process |
| 05/02/2001 | CN1293040A Amino acid gelatin pill |
| 05/02/2001 | CN1293039A 氨基酸胶囊 Amino acid capsules |
| 05/02/2001 | CN1065137C Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor |
| 05/02/2001 | CN1065134C Medicine for treatment of stone |
| 05/02/2001 | CN1065133C External used paste for treatment of pimple |
| 05/02/2001 | CN1065132C Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc |
| 05/02/2001 | CN1065129C Medicine good for heart |
| 05/01/2001 | US6225354 Subjecting unsaponified beeswax to liquid extraction with liquid organic extractant in which primary aliphatic alcohols are soluble; recovering alcohol mixture and isolating alcohols |
| 05/01/2001 | US6225323 Activated iododerivatives for the treatment of cancer and AIDS |
| 05/01/2001 | US6225291 Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases |
| 05/01/2001 | US6225289 Methods and compositions for preserving adenoviral vectors |
| 05/01/2001 | US6225119 Generating hematopoietic cells in vitro; for use in the treatment of blood disorders |
| 05/01/2001 | US6225113 Genetically engineered vector for the transcription of heterologous genes in cells |
| 05/01/2001 | US6225104 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids |
| 05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225042 Culturing genetically engineered, antigen presenting insect cell line so that major histocompatibility class i molecules bound to selected peptide are produced on surface of cell, then contacting with cd8 t cells |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224863 Antibiotic composition from alcaligenes species and method for making and using the same |
| 05/01/2001 | US6224859 Composition containing immature mammalian dendritic cells for enhancing tolerogenicity to foreign graft |
| 05/01/2001 | CA1341221C Irradiation of blood products |
| 05/01/2001 | CA1341220C Cloning and characterization of the bovine interleukin-2-gene |
| 05/01/2001 | CA1341219C Site specific mutagenesis in alpha-1-antitrypsin |
| 04/26/2001 | WO2001029244A1 Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 04/26/2001 | WO2001029234A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029209A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029200A1 DNA ENCODING ENDO-β-GALACTOSIDASE |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029198A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | WO2001029193A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 04/26/2001 | WO2001029192A2 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
| 04/26/2001 | WO2001029191A1 Method of in vitro culture of lymphocytes and gene therapy compositions |
| 04/26/2001 | WO2001029189A2 Synthetic substrate for tissue formation |
| 04/26/2001 | WO2001029184A1 Powdery compositions of liquid aureobasidium culture, process for producing the same and powdery mixtures by using these compositions |
| 04/26/2001 | WO2001029182A1 Novel compound, wf217 |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001028599A1 Isoalloxazine derivatives to neutralize biological contaminants |
| 04/26/2001 | WO2001028584A1 Treatment of respiratory diseases and infections |
| 04/26/2001 | WO2001028574A2 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 04/26/2001 | WO2001028573A2 Monocyte conditioned medium for cancer treatment |
| 04/26/2001 | WO2001028547A1 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 04/26/2001 | WO2001028515A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | WO2001028342A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2001000788A3 Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells |
| 04/26/2001 | WO2000073421A3 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000070021A3 Differentiated human embryoid cells and a method for producing them |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | US20010000473 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 04/26/2001 | DE19951072A1 New cell constructs from activated T-cells of patients useful as a medicament |
| 04/26/2001 | DE19949589A1 Differentiating immature myeloid precursor cells, useful for producing active granulocytes for treatment of infections, comprises in vitro culture |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2387855A1 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | CA2387748A1 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 04/26/2001 | CA2387580A1 Synthetic substrate for tissue formation |
| 04/26/2001 | CA2387392A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | CA2387185A1 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | CA2387041A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | CA2386422A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | CA2386401A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 04/25/2001 | WO2003054202A1 Generation of human neural crest stem cell line and its utilization in human transplantation |
| 04/25/2001 | EP1094317A1 Method to identify compounds which modulate FRA-1 expression |
| 04/25/2001 | EP1094079A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1094078A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1093803A2 Cosmetic composition comprising antagonist of the neuropeptide Y receptor |
| 04/25/2001 | EP1093720A1 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1093519A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |